These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33217135)

  • 1. Is the atypical hemolytic uremic syndrome risk polymorphism in Membrane Cofactor Protein MCPggaac relevant in kidney transplantation? A case report.
    Sánchez-Moreno A; de la Cerda F; Rodríguez-Barba A; Fijo J; Bedoya R; Arjona E; de Córdoba SR
    Pediatr Transplant; 2021 May; 25(3):e13903. PubMed ID: 33217135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relevance of the MCP Risk Polymorphism to the Outcome of aHUS Associated With C3 Mutations. A Case Report.
    Lumbreras J; Subias M; Espinosa N; Ferrer JM; Arjona E; Rodríguez de Córdoba S
    Front Immunol; 2020; 11():1348. PubMed ID: 32765494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R; Bonaudo R; Peruzzi RL; Amore A; Brunati A; Romagnoli R; Salizzoni M; Galbusera M; Gotti E; Daina E; Noris M; Remuzzi G
    Pediatr Nephrol; 2016 May; 31(5):759-68. PubMed ID: 26604087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations.
    Pabst WL; Neuhaus TJ; Nef S; Bresin E; Zingg-Schenk A; Spartà G
    Pediatr Nephrol; 2013 Jul; 28(7):1141-4. PubMed ID: 23519521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.
    Kim S; Park E; Min SI; Yi NJ; Ha J; Ha IS; Cheong HI; Kang HG
    J Korean Med Sci; 2018 Jan; 33(1):e4. PubMed ID: 29215813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M; Caprioli J; Bresin E; Mossali C; Pianetti G; Gamba S; Daina E; Fenili C; Castelletti F; Sorosina A; Piras R; Donadelli R; Maranta R; van der Meer I; Conway EM; Zipfel PF; Goodship TH; Remuzzi G
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1844-59. PubMed ID: 20595690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E; Rurali E; Caprioli J; Sanchez-Corral P; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Pinto S; Goodship TH; Alberti M; Ribes D; Valoti E; Remuzzi G; Noris M;
    J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
    Vondrák K; Seeman T
    Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.
    Stea ED; Skerka C; Accetturo M; Pesce F; Wiech T; Hartman A; Pontrelli P; Conserva F; Castellano G; Zipfel PF; Gesualdo L
    Front Immunol; 2022; 13():1008294. PubMed ID: 36451836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP.
    Cruzado JM; de Córdoba SR; Melilli E; Bestard O; Rama I; Sánchez-Corral P; López-Trascasa M; Navarro I; Torras J; Gomà M; Grinyó JM
    Am J Transplant; 2009 Jun; 9(6):1477-83. PubMed ID: 19459807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different approaches to long-term treatment of aHUS due to MCP mutations: a multicenter analysis.
    Klämbt V; Gimpel C; Bald M; Gerken C; Billing H; Loos S; Hansen M; König J; Vinke T; Montoya C; Lange-Sperandio B; Kirschstein M; Hennies I; Pohl M; Häffner K
    Pediatr Nephrol; 2021 Feb; 36(2):463-471. PubMed ID: 32715379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
    Nga HS; Palma LMP; Ernandes Neto M; Fernandes-Charpiot IMM; Garcia VD; Kist R; Miranda SMC; Macedo de Souza PA; Pereira GM; de Andrade LGM
    PLoS One; 2021; 16(11):e0258319. PubMed ID: 34748552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.
    Le Quintrec M; Zuber J; Moulin B; Kamar N; Jablonski M; Lionet A; Chatelet V; Mousson C; Mourad G; Bridoux F; Cassuto E; Loirat C; Rondeau E; Delahousse M; Frémeaux-Bacchi V
    Am J Transplant; 2013 Mar; 13(3):663-75. PubMed ID: 23356914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetics of aHUS and transplant recurrence].
    Bresin E
    G Ital Nefrol; 2015; 32 Suppl 64():. PubMed ID: 26479051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical hemolytic-uremic syndrome: recurrent phenotypic expression of a patient with MCP gene mutation combined with risk haplotypes.
    Marini SC; Gomes M; Guilherme R; Carda JP; Pinto CS; Fidalgo T; Ribeiro ML
    Blood Coagul Fibrinolysis; 2019 Mar; 30(2):68-70. PubMed ID: 30676336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.